A trial of immunotherapy against Leishmania amazonensis infection in vitro and in vivo with Z-100, a polysaccharide obtained from Mycobacterium tuberculosis, alone or combined with meglumine antimoniate

The Journal of Antimicrobial Chemotherapy
Paola Andrea BarrosoYoshihisa Hashiguchi


To determine the efficacy and the immunomodulatory function of Z-100 alone or combined with meglumine antimoniate on Leishmania amazonensis infection. The effect of the compounds was evaluated by microscopic counting of intracellular amastigotes in macrophages stained with Giemsa, or axenic promastigotes, and IC(50) was determined by linear regression. The antileishmanial effect of the compounds was assessed in infected BALB/c mice by a limiting dilution analysis and the production of gamma interferon (IFN-gamma), interleukin 10 (IL-10), IL-4, IgG1 and IgG2a was measured by ELISA. In vitro, Z-100 showed antileishmanial activity against intracellular amastigotes of L. amazonensis with an IC(50) of 13 mg/L. Moreover, infected macrophages treated with Z-100 (12 mg/L) showed smaller parasitophorous vacuoles with fewer parasites than the control. In addition, the efficacy of Z-100 plus meglumine antimoniate [14 mg/L pentavalent antimony (Sb(v))] was higher (46% inhibition) than either Z-100 or meglumine antimoniate alone. Nevertheless, no effect of Z-100 on axenic promastigotes was observed. Infected BALB/c mice treated with Z-100 (100 microg/kg) alone did not show any antileishmanial effects in comparison with the control group, an...Continue Reading


Mar 1, 1985·The American Journal of Tropical Medicine and Hygiene·L E Adinolfi, P F Bonventre
Aug 1, 1981·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·H KobatakeH Kushida
Jan 1, 1982·The American Journal of Tropical Medicine and Hygiene·J L AvilaJ Convit
May 19, 2000·Antimicrobial Agents and Chemotherapy·A C SmithS L Croft
Feb 22, 2001·Antimicrobial Agents and Chemotherapy·F FrézardM A Costa
Apr 4, 2001·Memórias do Instituto Oswaldo Cruz·V P ToledoL C Afonso
Feb 15, 2003·BMJ : British Medical Journal·Clive R DaviesShyam Sundar
Sep 23, 2003·The Journal of Immunology : Official Journal of the American Association of Immunologists·Udaikumar M PadigelJay P Farrell
Feb 1, 1997·Parasitology Today·H C LimaR G Titus

❮ Previous
Next ❯


Aug 21, 2013·The Journal of Antimicrobial Chemotherapy·Kevin J PeineEric M Bachelder
Sep 10, 2013·Research in Veterinary Science·D B BentoP R Romão
Aug 1, 2014·Expert Opinion on Biological Therapy·Ali Khamesipour
Dec 14, 2011·Archives of Medical Research·Fatemeh DehghaniNariman Mossaffa
Dec 17, 2014·European Journal of Medicinal Chemistry·Alex Evangelista do AmaralGuilhermina Rodrigues Noleto
Aug 31, 2011·International Immunopharmacology·Piu SahaMitali Chatterjee
Oct 25, 2016·PLoS Neglected Tropical Diseases·Mohammad IslamuddinFarhat Afrin
Dec 16, 2016·Parasitology·Y TaslimiS Rafati
Dec 21, 2011·Revista Do Instituto De Medicina Tropical De São Paulo·Diana Copi AyresSelma Giorgio
Dec 13, 2016·Transactions of the Royal Society of Tropical Medicine and Hygiene·Anuradha Ratna, Sunil K Arora
Dec 19, 2019·Microorganisms·Camila Dos Santos Meira, Lashitew Gedamu
Oct 23, 2009·The Journal of Physical Chemistry. B·Katarzyna Hac-WydroRadosław Zuk
Jul 15, 2015·International Journal of Biological Macromolecules·Monica Mendes Kangussu-MarcolinoGuilhermina Rodrigues Noleto

❮ Previous
Next ❯

Related Concepts

Trending Feeds


Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.


Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.


Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.